What OATS mosaicplasty does to damaged knee cartilage

Surgeons performing OATS take a small cylindrical plug of bone and cartilage — complete with the overlying hyaline surface — from a part of the knee that bears little load during normal walking, and press-fit it into the damaged area. The cartilage arrives ready-made, already mature, already integrated with its supporting bone. Think of it as lifting an undamaged tile from a hidden corner of the floor and relaying it precisely where the surface has worn through.

In the mosaicplasty variant, several small-diameter plugs — typically 6–10 mm across — are arranged side by side to fill larger focal defects, up to roughly 4 cm². Where the lesion is smaller, in the 1–2 cm² range, a single plug often suffices. Either way, the procedure is completed in a single operating session, arthroscopic-assisted, under general or spinal anaesthetic.

Microfracture takes a fundamentally different route: small holes are drilled into the bone to provoke a healing clot, and what forms is fibrocartilage — a structurally distinct, mechanically inferior tissue. OATS repositions tissue that already exists; nothing is synthesised or substituted. That distinction explains why durability expectations for the two techniques diverge, particularly beyond the first few years after surgery.

The procedure is generally considered for patients with a focal, contained ICRS grade III or IV defect who remain symptomatic despite a genuine trial of conservative management — typically young-to-middle-aged adults with an active lifestyle and a lesion that has not responded to physiotherapy or injection support.

Pain, function, and activity at 10-year follow-up

The long-term functional evidence for OATS is reassuring and consistent. Pareek et al.'s 2016 systematic review, focused specifically on 10-year follow-up data, found that both IKDC and Lysholm scores — the two most widely used measures of knee pain and function — improved significantly from pre-operative baseline and remained improved at the decade mark. These are durable gains, not early post-surgical effects that fade with time.

One nuance deserves attention, particularly for active patients. Tegner activity scores, which measure the intensity of physical activity rather than symptoms alone, did not significantly change at 10-year follow-up in the same systematic review. In practical terms, most patients experience genuine and lasting relief from pain and regain functional capacity, but may not fully return to the same intensity of sport or physical demand they had before the injury — a ceiling worth discussing before surgery rather than discovering after it.

The case for restoring the joint surface, rather than simply removing damaged tissue, is reinforced by a separate body of long-term evidence. Sanders et al. (American Journal of Sports Medicine, 2017) followed patients for a mean of 16 years after treatment for osteochondritis dissecans, and found that those managed by fragment excision alone — without surface restoration — showed substantially higher subsequent rates of osteoarthritis than those who underwent a restorative procedure. The implication carries across cartilage lesion types: decisions made at the time of intervention compound over decades, and leaving the joint surface unreconstructed carries a meaningful long-term OA burden.

The available evidence on 10-year outcomes comes from systematic reviews and observational cohorts rather than randomised head-to-head trials — a limitation worth noting, though the findings are consistent across the literature.

Return to sport — realistic rates and timelines for active adults

For competitive athletes, the most cited figures come from soccer cohort studies: 83% of players returned to sport after OATS or mosaicplasty, 80% did so at the same competitive level, and 87–100% maintained the ability to play at five years postoperatively — rates described in the literature as the highest reported across any cartilage restoration procedure. Campbell et al.'s large systematic review, pooling 1,117 patients, corroborates this picture at a broader level, finding that OAT delivered significantly higher return-to-sport rates than alternative cartilage procedures.

These figures come predominantly from competitive athletes, which sets the ceiling. Recreational active adults — weekend runners, club-level cyclists, recreational skiers — may achieve solid return to sport without reaching the same rates, and individual variation is substantial. Positive prognostic factors in the published evidence are younger age (under 25) and smaller defect size (under 2 cm²); patients who meet both criteria tend to achieve the best outcomes.

One trade-off deserves honest pre-operative discussion. Return to previous sports activity takes significantly longer after mosaicplasty than after microfracture, reflecting the greater surgical complexity and the demands of osseointegrating multiple plugs before loading. Exact timelines vary with defect size, graft number, rehabilitation compliance, and sport type, and should be individualised at consultation. The speed advantage of microfracture, however, is substantially undermined by its documented outcome decline at two to three years — making the longer recovery after mosaicplasty a considered exchange for durability rather than simply a complication.

Why OATS outperforms microfracture over the long term

The distinction begins in the operating theatre but plays out over years. Microfracture works by puncturing the subchondral bone plate to release marrow-derived stem cells, which consolidate into a clot and, over several months, produce fibrocartilage — a tissue composed predominantly of Type I collagen. Hyaline cartilage, the tissue that OATS transplants intact, is built on a Type II collagen scaffold with a structured extracellular matrix designed to absorb and distribute compressive and shear loads across the joint surface. These two tissues are not biomechanically interchangeable, and that difference is the root cause of the divergence in long-term outcomes.

At shorter follow-up intervals, the gap is not always visible in the numbers. Lim et al.'s Level 2 comparison found no statistically significant difference in Lysholm or Tegner scores between microfracture and OAT at earlier time points, suggesting both procedures can produce meaningful initial improvement. The divergence becomes apparent as follow-up lengthens: fibrocartilage degrades under repetitive compressive load in ways that native hyaline cartilage does not, and the clinical literature consistently reflects this deteriorating trajectory for microfracture over time. There is a further downstream consideration: repeated or aggressive subchondral bone drilling can damage the bone plate itself, potentially narrowing the options for any future revision cartilage procedure.

A randomised trial comparing mosaicplasty with microfracture at a 10-year endpoint in active adults does not yet exist — the long-term advantage rests on mechanistic reasoning combined with consistent trends from observational series. For patients whose joint needs to perform for decades rather than a single season, that mechanistic case carries real clinical weight.

The trade-offs specific to mosaicplasty

Mosaicplasty differs from single-plug OATS in one structurally important way: the technique uses multiple small-diameter cylinders rather than one larger graft, and the gaps between those cylinders do not fill with hyaline cartilage. Instead, fibrocartilage ingrows to occupy the inter-graft spaces. The repaired surface is therefore a mosaic in a literal sense — predominantly hyaline, but with fibrocartilage bridges running between plugs. This is a meaningful biological compromise worth discussing pre-operatively, even if the overall environment remains sufficiently hyaline to explain why outcomes consistently exceed those of microfracture.

Donor-site morbidity is a separate and clinically real consideration. Harvesting plugs from a low-load zone of the knee introduces the possibility of harvest-site pain and, less commonly, local cartilage damage at the donor area. Long-term series often under-report this outcome, so the full picture at 10 years remains incompletely characterised — a gap patients should raise explicitly at consultation rather than assume has been resolved in the published evidence.

At the upper size limit of mosaicplasty — around 4 cm² — ACI, MACI, or osteochondral allograft (OCA) may be considered depending on individual factors. OCA data from series with more than three years of follow-up report reoperation rates of 34–53%, a figure that usefully contextualises one advantage of autograft: where harvest is feasible, autograft durability appears generally superior to allograft.

Mosaicplasty does retain one logistical advantage over ACI and MACI: it is completed in a single operative stage, avoiding the biopsy-to-reimplantation interval that two-stage cell-based procedures require — a meaningful difference in terms of overall patient journey and time off work.

Who is a good candidate for OATS mosaicplasty

Selecting the right patients is where good outcomes begin. The clearest candidates are active adults — typically under 50, with the best results consistently reported in those under 25 — who have a focal, contained cartilage defect that has not responded to conservative management. A single-plug OATS procedure is most suitable for defects up to around 2 cm²; the mosaicplasty technique extends that range to approximately 4 cm², though with the fibrocartilage trade-off covered in the previous section.

Several factors shift the conversation elsewhere. A BMI above 40, age over 50, osteoarthritis graded beyond Kellgren-Lawrence grade 2, or a diagnosis of inflammatory arthritis each indicate that a different pathway — whether another preservation strategy or joint replacement planning — is likely to be more appropriate. These are not barriers to treatment as such; they are directional signals worth exploring at a specialist consultation.

Alignment deserves particular attention. Varus or valgus malalignment loads the repaired compartment disproportionately, and in those cases a corrective osteotomy (high tibial osteotomy or distal femoral osteotomy) may be considered alongside or prior to the cartilage procedure. Prior microfracture does not automatically rule out OATS, but damage to the subchondral bone plate from marrow stimulation warrants careful MRI review and surgical planning.

Positive prognostic factors for return to sport — younger age and lesion size below 2 cm² — reinforce that earlier assessment, before a defect enlarges or the surrounding joint deteriorates, produces the most options. Patients who want an independent specialist opinion without waiting for a GP referral can arrange assessment at mskdoctors.com.

1. [1] Articular cartilage stem cell paste grafting. https://en.wikipedia.org/?curid=36740925 https://en.wikipedia.org/?curid=36740925